Siemens Healthineers: A leading medical technology company specializing in robotics, imaging, and advanced therapy solutions. Siemens Healthineers brings deep expertise in robotic systems and image-guided therapy to enhance clinical outcomes.
Stryker: A global leader in neurovascular technologies and medical devices, Stryker focuses on developing innovative solutions for treating stroke, aneurysms, and other neurovascular conditions.
Stryker and Siemens Healthineers have formed a strategic partnership to develop a first-of-its-kind robotic system for comprehensive neurovascular procedures, including stroke and aneurysm treatments.
The collaboration integrates robotics, imaging, and neurovascular devices into a single ecosystem aimed at improving procedural precision and physician performance.
Stroke is a major global health burden, being the second-leading cause of death and third-leading cause of disability worldwide.
The robotic system will support both elective and emergency neurovascular procedures, addressing complex hemorrhagic cases and time-sensitive ischemic strokes.
Initial phases will focus on co-developing the system, integrating devices, validating clinical value, and optimizing procedural workflows.
Neurovascular procedures are highly complex, requiring physicians to manage multiple systems simultaneously, which can reduce efficiency and increase procedural risks.
There is a need for faster intervention in stroke cases to improve survival and recovery rates.
Precision is critical in treating delicate brain vasculature, where even small errors can have significant consequences.
Designing an integrated robotic system that combines imaging, therapy devices, and procedural workflow optimization.
Collaborating with leading physicians to validate the system’s clinical value and ensure it meets real-world workflow requirements.
Developing a comprehensive ecosystem that improves physician performance, procedural precision, and patient outcomes.
The global neurovascular devices market size is calculated at USD 7.37 billion in 2024, grew to USD 7.8 billion in 2025, and is projected to reach around USD 12.94 billion by 2034. The market is expanding at a CAGR of 5.79% between 2025 and 2034.
Siemens Healthineers: Provides expertise in robotics and imaging for robotic navigation and image-guided therapy.
Stryker: Contributes its neurovascular device experience, including access devices and therapy implants, and focuses on clinical application in stroke and aneurysm treatments.
Joint Responsibility: Co-develop the robotic system, optimize procedural workflows, and validate clinical effectiveness.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
